GOOD DAY FOR: A drug war, as Pfizer, the world’s largest drugmaker, is considering a counteroffer for Indian generics giant Ranbaxy Laboratories, the Business Standard newspaper reported. Japan’s Daiichi Sankyo bid $4.6 billion for Ranbaxy earlier this week. A Ranbaxy spokesman called the report “speculation,” adding, “We have a binding contract with Daiichi. It is a final contract.” (Reuters)
BAD DAY FOR: Overpacking, after United Airlines and US Airways both said they will charge $15 for passengers’ first checked bag, following American Airlines’ lead. Most U.S. airlines, except for Southwest, already charge $25 for checking a second piece of luggage. US Airways also said it will cut 1,700 jobs, shrink its fleet, and start charging for all in-flight beverages. (AP in Yahoo! Finance)
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Campus security is in the public eye again after the Brown shootingTalking Points Questions surround a federal law called the Clery Act
-
9 new cookbooks begging to be put to good winter usethe week recommends Booze-free drinks, the magic versatility of breadcrumbs and Japanese one-pot cooking
-
Bari Weiss’ ‘60 Minutes’ scandal is about more than one reportIN THE SPOTLIGHT By blocking an approved segment on a controversial prison holding US deportees in El Salvador, the editor-in-chief of CBS News has become the main story
